Nalaganje...
Comparative Effectiveness of Adjunctive Bevacizumab for Advanced Lung Cancer: The Cancer Research Network Experience
INTRODUCTION: Bevacizumab plus carboplatin-paclitaxel (BCP) chemotherapy has FDA approval for advanced non-squamous, non-small cell lung cancer (NS-NSCLC) based upon improved survival in a clinical trial. However, sub-group analyses of this and other studies have suggested variable results by age an...
Shranjeno v:
| izdano v: | J Thorac Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5083067/ https://ncbi.nlm.nih.gov/pubmed/24633407 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000127 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|